menu search

NLSP / NLS Pharmaceutics Company Update and Webcast Today Postponed

NLS Pharmaceutics Company Update and Webcast Today Postponed
NLS to Webcast its Event on Thursday, July 6, 2023, at 11:00 am ET ZURICH, SWITERLAND / ACCESSWIRE / June 30, 2023 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system disorders, today announced it will postpone its webcast previously scheduled for today due to important developments impacting the timing of the company update. Read More
Posted: Jun 30 2023, 08:00
Author Name: Accesswire
Views: 081096

NLSP News  

NLS Pharmaceutics shares rise as narcolepsy treatment moves to phase 3 studies

By Market Watch
July 3, 2023

NLS Pharmaceutics shares rise as narcolepsy treatment moves to phase 3 studies

Shares of NLS Pharmaceutics Ltd. NLSP, +19.57% gained 12% premarket on Monday after the Swiss clinical-stage biopharma company said it would proceed w more_horizontal

NLS Pharmaceutics Company Update and Webcast Today Postponed

By Accesswire
June 30, 2023

NLS Pharmaceutics Company Update and Webcast Today Postponed

NLS to Webcast its Event on Thursday, July 6, 2023, at 11:00 am ET ZURICH, SWITERLAND / ACCESSWIRE / June 30, 2023 / NLS Pharmaceutics Ltd. (NASDAQ:NL more_horizontal

CORRECTION FROM SOURCE: NLS Pharmaceutics to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

By Accesswire
June 19, 2023

CORRECTION FROM SOURCE: NLS Pharmaceutics to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest

Presentation to take place on Tuesday, June 20, 2023, at 10:30AM ET ZURICH, SWITZERLAND / ACCESSWIRE / June 19, 2023 / NLS Pharmaceutics Ltd. (Nasdaq: more_horizontal

NLS Pharmaceutics Announces Company Update Webcast

By Accesswire
June 19, 2023

NLS Pharmaceutics Announces Company Update Webcast

Members of Executive Leadership Team to Discuss initiation of Phase 3, Pipeline updates, Key Financials, Corporate Development, and the other topics N more_horizontal

NLS Pharmaceutics Announces Company Update Webcast

By Accesswire
June 15, 2023

NLS Pharmaceutics Announces Company Update Webcast

Members of Executive Leadership Team to Discuss initiation of Phase 3, Pipeline updates, Key Financials, Corporate Development, and the other topics N more_horizontal

4 Hot Penny Stocks To Watch This Week

By PennyStocks
August 22, 2022

4 Hot Penny Stocks To Watch This Week

Penny stocks to add to your watch list this week. The post 4 Hot Penny Stocks To Watch This Week appeared first on Penny Stocks to Buy, Picks, News an more_horizontal

NLS Pharma Shares Fall After Mazindol ER Interim Data Shows 39% Improvement On Sleepiness Scale

By Benzinga
March 16, 2022

NLS Pharma Shares Fall After Mazindol ER Interim Data Shows 39% Improvement On Sleepiness Scale

NLS Pharmaceutics Ltd (NASDAQ: NLSP) has announced interim topline data from its Phase 2a trial of its lead product candidate, Quilience (Mazindol more_horizontal

Why Are NLS Pharmaceutics Shares Trading Higher During Premarket Monday?

By Benzinga
February 7, 2022

Why Are NLS Pharmaceutics Shares Trading Higher During Premarket Monday?

NLS Pharmaceutics Ltd NLSP shares are trading higher after the Company announced to present interim topline data from its Phase 2a trial evaluating i more_horizontal


Search within

Pages Search Results: